Top Market Players:
1. Gilead Sciences, Inc.
2. Merck & Co., Inc.
3. Pfizer Inc.
4. F. Hoffmann-La Roche Ltd.
5. GlaxoSmithKline plc
6. Abbott Laboratories
7. Novartis International AG
8. Johnson & Johnson
9. AbbVie Inc.
10. Bristol-Myers Squibb Company
These companies are at the forefront of the CMV treatment market, driving innovation and competition in the industry. They have a strong global presence and are continuously investing in research and development to bring new and improved treatment options to patients suffering from CMV. Their market leadership positions them as key players in shaping the future of the CMV treatment market.